Improving lives with high-quality, science-based cannabinoid active pharmaceutical ingredients

MANUFACTURED IN SWITZERLAND

Linnea has been a pioneering pharmaceutical manufacturer of premium botanical ingredients for over 40 years, distinguishing itself through expertise, quality and innovation.

Since its founding in 1982, Linnea has focused on developing top-tier plant-based Active Pharmaceutical Ingredients at its GMP-certified facility in Switzerland. Known for its dedication to excellence, Linnea ensures every ingredient adheres to rigorous standards, with a particular emphasis on the compliance of herbal starting materials with GACP standards.

TRUST AND EXPERIENCE
GMP CERTIFIED SITE
GACP COMPLIANT

Discover our mission

As of 2014, the company has expanded its focus to cannabinoid research and development, launching its first full pharma-grade cannabinoid ingredient in 2016.

This marked the beginning of our commitment to applying the same science-based, uncompromising approach to the pharmaceutical manufacturing of cannabinoids from natural Cannabis Sativa L. for customers worldwide.

FOCUS ON RESEARCH

More on our approach

Looking ahead, Linnea is poised to strengthen its operations with a new state-of-the-art manufacturing plant dedicated exclusively to medical cannabis derivatives.

This positions the company as one of the very few industry leaders devoted to the highest levels of quality, ensuring sustained growth and cutting-edge advancements through 2025 and beyond.

LINNEA’S CANNABINOID ISOLATES, EXTRACTS AND DILUTIONS ARE AVAILABLE FOR PHARMACEUTICAL INDUSTRIES WORLDWIDE


PHARMACEUTICALS
GMP-certified, pharma grade standardized cannabinoid preparations:

Through our qualified contract manufacturing partner, we offer our clients packaging and labeling services tailored to their specific needs.

We supply GMP pharmaceutical preparations in bulk for companies and pharmacies under GID “Guarantee of Identity”. Ready-to-market products are in compliance with the Swiss Pharmacopoeia.

Linnea implements a short supply chain model to preserve the integrity of the phytocomplex. Linnea’s handling of cannabinoid ingredients is fully compliant with international import/export regulations for controlled substances.

GID AUTHORIZATION CERTIFIED BY SWISSMEDIC

Enquiry now Memberships

A map with all the continents with various marked locations that provide information regarding conference dates for quarter one and two of 2024 to meet the Linnea team.

MAIN EVENTS SEPTEMBER/OCTOBER 2025


Linnea is pleased to invite you to meet our team at these upcoming international events:

OCTOBER


Step

28–30 October
CPHI Worldwide
Frankfurt, Germany
Messe Frankfurt
> Meet us at Meet us at Integrated Pharma Pavillion | Booth 9.1D78

Schedule your live or virtual appointment now with the Linnea team:

Cannabinoid education, Community and Thought Leadership


Linnea goes beyond manufacturing to support our customers, connect with the business community, and educate worldwide about the potential therapeutic benefits of cannabinoids

Sign up to receive the latest Linnea® Cannabinoids news: